A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary purpose of the study is to evaluate the safety and tolerability of single ascending doses of UCB7853 in healthy male study participants and to evaluate the safety and tolerability of multiple ascending doses of UCB7853 administered in study participants with Parkinson\'s Disease (PD)
Epistemonikos ID: a2becf758e23beb1f2afe432985e2c4b97356179
First added on: May 07, 2024